Study: Cancer drugs on sale faster in US than Europe

June 17, 2011 4:42:12 AM PDT
When it comes to cancer drugs, patients in the United States are more likely to get the newest therapies before they go on sale in Europe, according to a study published online in the journal Health Affairs.

Researchers say the findings counter a common belief that new oncology drugs often win approval in Europe first.

The study shows new cancer medications typically reach the U.S. market several months before they are available to patients in Europe.

The Food and Drug Administration has been criticized by some manufacturers as being too cautious in analyzing drugs as well as medical devices.